These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 24614629

  • 1. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A, Tekiner F, Karakurt A, Sirin G, Duman D.
    Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
    [Abstract] [Full Text] [Related]

  • 2. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K, Li YJ, Gao S.
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.
    Yılmaz S, Sen F, Ünal S, Yayla C, Özeke Ö, Aras D, Topaloglu S, Aydogdu S.
    Scand Cardiovasc J; 2015 Feb; 49(1):39-44. PubMed ID: 25414124
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
    Turak O, Canpolat U, Özcan F, Mendi MA, Oksüz F, Işleyen A, Gürel OM, Çay S, Aras D, Aydoğdu S.
    Am J Cardiol; 2014 Jan 15; 113(2):197-202. PubMed ID: 24157191
    [Abstract] [Full Text] [Related]

  • 7. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease.
    Kurtul A, Murat SN, Yarlioglues M, Duran M, Karadeniz M, Ergun G, Akyel A, Mendi MA, Oksuz F.
    Platelets; 2015 Jan 15; 26(1):48-52. PubMed ID: 24831828
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP, Xu WT, Wang L, Li H, Shao CL, Gu HB, Chan SP, Xu HF, Yang XJ.
    Coron Artery Dis; 2015 Jan 15; 26(1):5-10. PubMed ID: 25211654
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis.
    Turak O, Ozcan F, Isleyen A, Tok D, Sokmen E, Buyukkaya E, Aydogdu S, Akpek M, Kaya MG.
    Am J Cardiol; 2012 Nov 15; 110(10):1405-10. PubMed ID: 22858185
    [Abstract] [Full Text] [Related]

  • 13. Bare metal stent restenosis is not a benign clinical entity.
    Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL.
    Am Heart J; 2006 Jun 15; 151(6):1260-4. PubMed ID: 16781233
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
    Kang SJ, Cho YR, Park GM, Ahn JM, Han SB, Lee JY, Kim WJ, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Mintz GS, Park SJ.
    JACC Cardiovasc Imaging; 2013 Nov 15; 6(11):1183-90. PubMed ID: 24229771
    [Abstract] [Full Text] [Related]

  • 16. Preprocedural Albumin Levels and Risk of In-Stent Restenosis After Coronary Stenting With Bare-Metal Stent.
    Celik IE, Yarlioglues M, Kurtul A, Duran M, Koseoglu C, Oksuz F, Aksoy O, Murat SN.
    Angiology; 2016 May 15; 67(5):478-83. PubMed ID: 26243483
    [Abstract] [Full Text] [Related]

  • 17. Red cell distribution width in coronary heart disease: prediction of restenosis and its relationship with inflammatory markers and lipids.
    Qian H, Luo Z, Xiao C, Chen J, Li D, Xu H, He P, Zhou X, Zhang T, Min X.
    Postgrad Med J; 2018 Sep 15; 94(1115):489-494. PubMed ID: 30301834
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.
    JACC Cardiovasc Interv; 2013 Oct 15; 6(10):1026-34. PubMed ID: 24055443
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
    Almalla M, Schröder J, Pross V, Marx N, Hoffmann R.
    Catheter Cardiovasc Interv; 2014 May 01; 83(6):881-7. PubMed ID: 23765557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.